# 2026-07-16 Final Full-Feature Audit Report

> Program calendar window: 2026-03-13 to 2026-07-16
> Documentation executed on: 2026-03-13
> Program mode: Stable Baseline

## Executive Outcome

The audit program is complete.

The product is **not** release-ready.

Final decision:

- `NO GO`

## 1. Program Completion Summary

| Phase | Outcome | Key result |
|---|---|---|
| `Phase 0` | complete | audit charter, severity rubric, evidence model, and master registers frozen |
| `Phase 1` | complete | verification foundation, role/data matrix, and smoke baseline frozen |
| `Phase 2` | complete | auth, billing, invite, and permission `P0` bugs identified and classified |
| `Phase 3` | complete | core workspace save/recovery truth audited |
| `Phase 4` | complete | support surfaces audited and support regression pack defined |
| `Phase 5` | complete | team/share/admin boundary audit completed and admin `P0` exposure confirmed |
| `Phase 6` | complete | public/mobile/locale/docs consistency gaps classified |
| `Phase 7` | complete | resilience, recovery, performance, and observability posture classified |
| `Phase 8` | complete | final release gate, known-risk register, and next-cycle backlog produced |

## 2. Final Defect Landscape

| Class | Count | Notes |
|---|---:|---|
| Open `P0` | 5 | release blocked on auth, billing, canvas durability, admin RBAC, and mobile log exposure |
| Open `P1` | 10 | major core/public/mobile defects remain triaged but unresolved |
| Open `P2` | 6 | important but non-blocking defects remain |
| Open `P3` | 1 | low-risk public-link defect remains |
| Open `R3` risks | 4 | save coverage, fixture reproducibility, observability, and resilience automation are still open |

## 3. Highest-Impact Findings

### Release-blocking bugs

- `BUG-0001` reset-password recovery is brittle
- `BUG-0002` billing boundary is wrong for team members
- `BUG-0004` canvas undo/redo is not durably truthful
- `BUG-0013` Prompt Studio backend has missing admin RBAC
- `BUG-0022` mobile production logs expose auth and private content

### Systemic blockers

- product regression packs are still manual-only through `REG-05`
- resilience/recovery pack `REG-06` is still missing
- reproducible seed/reset support is unresolved
- observability remains insufficient for safe recovery incidents

## 4. What The Audit Achieved

```text
Program value delivered
=======================

Before this audit
  -> broad uncertainty
  -> no unified bug language
  -> no phase gate structure
  -> no full-product risk picture

After this audit
  -> every major surface has been decomposed and reviewed
  -> confirmed defects are classified by severity and surface
  -> regression gaps are explicit instead of hidden
  -> release decision is evidence-backed, not intuitive
```

## 5. Why The Final Gate Is `NO GO`

The final gate is blocked for four separate reasons:

1. Open `P0` defects still exist.
2. No product-level executable regression suite exists for the audited surfaces.
3. Mobile resilience and observability are not safe enough for release.
4. Public/mobile/content-integrity issues remain open on outward-facing surfaces.

## 6. Robust Path To `GO`

The next-cycle backlog defines the re-gate path. In condensed form:

1. Close all `P0` blockers.
2. Build `REG-06` and make critical existing packs executable.
3. Add structured redacted recovery instrumentation and UTF-8/content guards.
4. Close the high-risk `P1` core/public/mobile issues.
5. Re-run the full gate on a release candidate.

## 7. Planning Baseline From Current State

For a robust re-opened release gate from the state documented in this report:

- best-case focused closure path: 7 weeks
- safer planning baseline: 9 weeks

This assumes dedicated parallel staffing for:

- blocker fixes
- regression automation
- observability/infrastructure
- product-surface remediation

## 8. Final Read

This program should be considered closed as an audit program and open as a remediation program.

That distinction matters:

- the audit work is complete
- the product release work is not

The repository now has a complete, phase-by-phase quality baseline and a clear evidence-backed backlog to reach a future `GO`.
